Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step

Anti-viral small molecules are currently lacking for treating coronavirus infection. The long development timescales for such drugs are a major problem, but could be shortened by repurposing existing drugs. We therefore screened a small library of FDA-approved compounds for potential severe acute re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Shiu-Wan, Shafi, Talha, Ford, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619434/
https://www.ncbi.nlm.nih.gov/pubmed/34835112
http://dx.doi.org/10.3390/v13112306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619434/
https://www.ncbi.nlm.nih.gov/pubmed/34835112
http://dx.doi.org/10.3390/v13112306

Ejemplares similares